Overview

A Study of Cariprazine in Patients With Chronic Stable Schizophrenia

Status:
Completed
Trial end date:
2010-08-31
Target enrollment:
Participant gender:
Summary
This is an outpatient study to evaluate the long-term safety, tolerability, and pharmacokinetics of cariprazine in patients with schizophrenia.
Phase:
Phase 2
Details
Lead Sponsor:
Forest Laboratories
Collaborator:
Gedeon Richter Ltd.
Treatments:
Cariprazine